KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

BeOne Medicines (ONC) Interest & Investment Income: 2022-2024

Historic Interest & Investment Income for BeOne Medicines (ONC) over the last 3 years, with Dec 2024 value amounting to $47.8 million.

  • BeOne Medicines' Interest & Investment Income fell 71.54% to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.2 million, marking a year-over-year decrease of 64.15%. This contributed to the annual value of $47.8 million for FY2024, which is 35.36% down from last year.
  • BeOne Medicines' Interest & Investment Income amounted to $47.8 million in FY2024, which was down 35.36% from $74.0 million recorded in FY2023.
  • BeOne Medicines' Interest & Investment Income's 5-year high stood at $74.0 million during FY2023, with a 5-year trough of $47.8 million in FY2024.
  • Over the past 3 years, BeOne Medicines' median Interest & Investment Income value was $52.5 million (recorded in 2022), while the average stood at $58.1 million.
  • Its Interest & Investment Income has fluctuated over the past 5 years, first soared by 41.02% in 2023, then tumbled by 35.36% in 2024.
  • Over the past 3 years, BeOne Medicines' Interest & Investment Income (Yearly) stood at $52.5 million in 2022, then surged by 41.02% to $74.0 million in 2023, then crashed by 35.36% to $47.8 million in 2024.